The required information typically includes: Diagnosis: Documentation of the patients condition, such as type 2 diabetes, obesity, hypertension, or cardiovascular issues, that warrants the use of a GLP-1 medication
Circulating concentrations of GLP-1 cause the beta-cells in the pancreas to release insulin, which lowers blood glucose, and activity in various regions of the central nervous system reduces appetite and enhances satiety
A possible mechanism to explain these results could be that an import of extracellular leucine or methionine would activate the Target Of Rapamycin (TOR) signaling pathway (Takahara et al., 2020
Personalized treatment ensures better safety and effectiveness
What overdosing looks like Tirzepatide overdose can cause severe nausea and vomiting leading to dehydration, hypoglycemia (dangerously low blood sugar) especially in people who also take diabetes medications, acute pancreatitis requiring hospitalization, severe gastrointestinal symptoms including uncontrollable diarrhea, and cardiovascular effects from rapid fluid and electrolyte shifts